Chest CT of lung injury 1 year after COVID-19 pneumonia: the CovILD study
AK Luger, T Sonnweber, L Gruber, C Schwabl, K Cima… - Radiology, 2022 - pubs.rsna.org
Background The long-term pulmonary sequelae of COVID-19 is not well known. Purpose To
characterize patterns and rates of improvement of chest CT abnormalities 1 year after …
characterize patterns and rates of improvement of chest CT abnormalities 1 year after …
Phenotyping of acute and persistent Coronavirus disease 2019 features in the outpatient setting: exploratory analysis of an international cross-sectional Online survey
…, A Boehm, M Aichner, K Cima… - Clinical Infectious …, 2022 - academic.oup.com
Background Long COVID, defined as the presence of coronavirus disease 2019 (COVID-19)
symptoms ≥28 days after clinical onset, is an emerging challenge to healthcare systems. …
symptoms ≥28 days after clinical onset, is an emerging challenge to healthcare systems. …
[HTML][HTML] Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) Statement …
…, BM Arns, J Bolitschek, B Bucher, K Cima… - Wiener Klinische …, 2020 - Springer
The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In
Austria, a crisis within the healthcare system has so far been prevented. The treatment of …
Austria, a crisis within the healthcare system has so far been prevented. The treatment of …
[HTML][HTML] The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)
K Cima, J Twiss, R Speich, SP McKenna… - Health and quality of life …, 2012 - Springer
Background Individuals with precapillary pulmonary hypertension (PH) experience severely
impaired quality of life. A disease-specific outcome measure for PH, the Cambridge …
impaired quality of life. A disease-specific outcome measure for PH, the Cambridge …
[HTML][HTML] Interstitial pulmonary fibrosis and extensive dendriform ossification with persistent viral load: A rare presentation of post-COVID-19 condition in need of lung …
JD Haslbauer, I Bratic-Hench, K Cima, AK Luger… - Pathobiology, 2023 - karger.com
The incidence, presentation, and predisposing factors of post-acute sequelae of COVID-19 (PASC)
are currently poorly understood. Lung explants may provide a rare insight into …
are currently poorly understood. Lung explants may provide a rare insight into …
Sensory neuropeptides are potent chemoattractants for human basophils in vitro
K Cima, H Vogelsinger, CM Kähler - Regulatory peptides, 2010 - Elsevier
The sensory neuropeptides secretoneurin (SN) and substance P (SP) are involved in “neurogenic”
inflammatory processes as they occur in bronchial asthma or allergic rhinitis. A …
inflammatory processes as they occur in bronchial asthma or allergic rhinitis. A …
[HTML][HTML] Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) Updated statement of the …
…, RH Zwick, BM Arns, J Bolitschek, K Cima… - Wiener Klinische …, 2022 - Springer
The Austrian Society of Pneumology (ASP) launched a first statement on severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time when in …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in May 2020, at a time when in …
[HTML][HTML] A spark of hope: histopathological and functional recovery after critical COVID-19
A Boehm, AK Luger, K Schmitz, K Cima… - Infection, 2022 - Springer
BACKGROUND There are substantial concerns about fibrotic and vascular pulmonary
sequelae after coronavirus disease 2019 (COVID-19) associated acute respiratory distress …
sequelae after coronavirus disease 2019 (COVID-19) associated acute respiratory distress …
Subarachnoid haemorrhage mimicking a STEMI
K Cima, A Grams, B Metzler - European Heart Journal: Acute …, 2017 - journals.sagepub.com
A 50-year-old healthy woman presented with typical ECG findings of a ST elevation
myocardial infarction, further to an abnormal anterior wall motion and elevated specific cardiac …
myocardial infarction, further to an abnormal anterior wall motion and elevated specific cardiac …
Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.
…, H Vogelsinger, S Desole, K Cima… - Wiener Klinische …, 2011 - search.ebscohost.com
Portopulmonary hypertension (POPH) is a rare complication of portal hypertension. Prostanoids
have been shown to be effective in the treatment of POPH and have been used as a …
have been shown to be effective in the treatment of POPH and have been used as a …
